MedPath

A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's Disease

Phase 3
Terminated
Conditions
Alzheimer's Disease
Interventions
Drug: Placebo
Registration Number
NCT05310071
Lead Sponsor
Biogen
Brief Summary

The primary objective of this study is to verify the clinical benefit of monthly doses of aducanumab in slowing cognitive and functional impairment as measured by changes in the Clinical Dementia Rating Scale Sum of Boxes (CDR-SB) score as compared with placebo in participants with early Alzheimer's disease.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
1512
Inclusion Criteria
  • The participant must have confirmed amyloid beta pathology by cerebrospinal fluid (CSF) or amyloid PET

  • Must have a history of subjective memory decline with gradual onset and slow progression over the 6 months before Screening, confirmed by study partner

  • The participant must have 1 informant/care partner who, in the Investigator's opinion, has frequent and sufficient contact with the participant (at least 10 hours/week in person or by phone) as to be able to provide accurate information about the participant's cognitive and functional abilities over time

  • Must meet all of the following clinical criteria for MCI due to Alzheimer's disease or mild Alzheimer's disease according to National Institute on Aging and Alzheimer's Association (NIA-AA) criteria

    1. Have an MMSE score between 22 and 30 inclusive
    2. Have a CDR memory score >0.5
    3. Have a Clinical Dementia Rating Scale Global Score (CDR-GS) of 0.5 or 1.0
    4. Have a Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) score of 85 or lower indicative of objective cognitive impairment
  • Apart from a clinical diagnosis of early Alzheimer's disease, the participant must be in good health as determined by the Investigator based on medical history and screening assessments

  • Must consent to apolipoprotein E (ApoE) genotyping. (Note: Participants are not required to be ApoE ε4 carriers)

Key

Exclusion Criteria
  • Any uncontrolled medical or neurological/neurodegenerative condition (other than Alzheimer's disease) that, in the opinion of the Investigator, might be a contributing cause of the participant's cognitive impairment
  • Clinically significant and/or unstable psychiatric illness within 6 months prior to Screening
  • Transient ischemic attack or stroke or any unexplained loss of consciousness within 1 year prior to Screening
  • History of severe allergic or anaphylactic reactions or of hypersensitivity to any of the inactive ingredients in the drug product
  • Participation in any study with purported disease-modifying effect in Alzheimer's disease within 12 months prior to Screening unless documentation of receipt of placebo is available
  • Current use or previous use of medications with a purported disease-modifying effect in Alzheimer's disease, outside of investigational studies
  • Use of any medications that, in the opinion of the Investigator, may contribute to cognitive impairment, put the participant at higher risk for AEs, or impair the participant's ability to perform cognitive testing or complete study procedures
  • Use of any investigational drug
  • Prior exposure to aducanumab either commercially or by participation in a previous study with aducanumab. (Participants are eligible if they did not receive active aducanumab.)
  • A negative PET scan result with any amyloid-targeting ligand within 12 months prior to Screening

NOTE: Other protocol defined Inclusion/Exclusion criteria may apply

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
AducanumabAducanumabParticipants will receive aducanumab, up to 10 milligrams per kilogram (mg/kg), monthly (once every four weeks), administered as intravenous (IV) infusion.
PlaceboPlaceboParticipants will receive placebo, monthly (once every four weeks), administered as IV infusion.
Primary Outcome Measures
NameTimeMethod
Change From Baseline in Clinical Dementia Rating Scale - Sum of Boxes (CDR-SB) Score at Week 78Baseline, Week 78

The Clinical Dementia Rate Scale integrates assessments from 3 domains of cognition (memory, orientation, judgment/problem-solving) and 3 domains of function (community affairs, home/hobbies, personal care). Following the caregiver interview and systematic participant examination, the rater assigns a score describing the participant's current performance level in each of these domains of life functioning. The "Sum of boxes" scoring methodology sums the score for each of the 6 domains and provides a value ranging from 0 to 18. Higher scores indicate greater impairment. A positive change from baseline indicates greater impairment.

Secondary Outcome Measures
NameTimeMethod
Change From Baseline in Integrated Alzheimer's Disease Rating Scale (iADRS) Score at Weeks 78 and 106Baseline, Weeks 78 and 106

The iADRS composite captures a decline in both cognition and daily function. It is a simple linear combination of the Alzheimer's disease assessment scale, cognitive subscale (ADAS-Cog13), and the Alzheimer's disease cooperative study scale for activities of daily living in mild cognitive impairment (ADCS-ADL-MCI). The ADAS-Cog13 scale ranges from 0 to 85 (higher scores indicate worse performance) and the ADCS-ADL-MCI scale ranges from 0 to 53 (higher scores indicate greater independent, healthy functioning). The total score for iADRS scale ranges from 0 to 138, where higher scores indicate better performance.

Change From Baseline in Alzheimer's Disease Cooperative Study for Activities of Daily Living in Mild Cognitive Impairment (ADCS-ADL-MCI) Scale Score at Weeks 78 and 106Baseline, Weeks 78 and 106

The ADCS-ADL-MCI scale consists of 17 instrumental items (e.g., shopping, preparing meals, using household appliances, etc) and 1 basic item (getting dressed). Ratings reflect caregiver observations about the participant's actual functioning over the previous month and provide an assessment of change in the functional state of the participant over time. The total score ranges from 0 to 53. Higher scores indicate greater independent, healthy functioning. A positive change from baseline indicates healthy functioning while a negative change from baseline indicates a decline in independent functioning.

Change From Baseline in Alzheimer's Disease Assessment Scale, Cognitive Subscale (ADAS-Cog13) at Weeks 78 and 106Baseline, Weeks 78 and 106

ADAS-Cog13 comprises both cognitive tasks and clinical ratings of cognitive performance. The cognitive subscale items capture word recall, ability to follow commands, the ability to correctly copy or draw an image, naming, the ability to interact with everyday objects, orientation, word recognition, memory, comprehension of spoken language, word-finding, and language ability, with a measure for delayed word recall and concentration/distractibility. The total score ranges from 0 to 85. Higher scores indicate worse performance. A positive change from baseline indicates decline in cognitive performance.

Change From Baseline in Mini-Mental State Examination (MMSE) Scale Score at Weeks 78 and 106Baseline, Weeks 78 and 106

The MMSE scale is a performance-based test of global cognitive status. It consists of 11 tasks that assess orientation, word recall, attention and calculation, language abilities, and visuospatial functions. The scores from the 11 tests are combined to obtain the total score, which ranges from 0 to 30. Higher scores indicate better performance. A negative change from baseline indicates decline in cognitive performance.

Change From Baseline in Neuropsychiatric Inventory-10 (NPI-10) Score at Weeks 78 and 106Baseline, Weeks 78 and 106

The NPI-10 is a questionnaire administered to the informant, designed to obtain information on the presence of neuropsychiatric symptoms and behaviors in a participant with Alzheimer's disease. Ten areas are assessed: delusions, hallucinations, agitation/aggression, depression, anxiety, elation/euphoria, apathy/indifference, disinhibition, irritability and aberrant motor behavior. The NPI total score ranges from 0 to 120. Higher scores indicate greater impairment. A negative change from baseline indicates improvement (symptom reduction).

Change From Baseline in Amyloid Positron Emission Tomography (PET) Signal at Weeks 78 and 104Baseline, Weeks 78 and 104

Amyloid PET scan assesses cerebral amyloid load using radiotracers which is standardized into centiloids. Centiloid values on centiloid scale is based on mean composite standardized uptake value ratio (SUVR).

Change From Baseline in Tau PET Signal at Weeks 78 and 104Baseline, Weeks 78 and 104

The cerebral tau level was measured by tau PET imaging. Tau PET imaging was conducted using radiotracer. SUVR is a ratio of PET uptake measured in brain region of interest and a disease-free reference region. A higher SUVR is an indication of increased PET radiotracer uptake and worsening disease.

Change From Baseline in CDR-SB Score at Week 106Baseline, Week 106

The CDR integrates assessments from 3 domains of cognition (memory, orientation, judgment/problem-solving) and 3 domains of function (community affairs, home/hobbies, personal care). Following caregiver interview and systematic participant examination, the rater assigns a score describing the participant's current performance level in each of these domains of life functioning. The CDR-SB sums the score for each of the 6 domains and provides a value ranging from 0 to 18. Higher scores indicate greater impairment. Positive change from baseline indicates greater impairment.

Change From Baseline in Global Statistical Test (GST) Composite Z-Score at Weeks 78 and 106Baseline, Weeks 78 and 106

GST z-score is an average of z-scores of CDR-SB, ADASCog13 and ADCS-ADL-MCI. CDR-SB assesses 3 cognitive (memory,orientation, judgment/problem-solving)and 3 functional(community affairs,home/hobbies,personal care) domains. Sum of Boxes method combines scores across 6 domains, ranging from 0-18(higher scores=greater impairment). ADAS-Cog13 evaluates cognitive tasks like word recall, naming, orientation and memory, with scores from 0-85 (higher scores=worse performance). ADCS-ADL-MCI rates 17 tasks (e.g.,shopping, preparing meal) and 1 basic task(dressing) with scores from 0-53 (higher scores=greater independence/healthy functioning). z-score\>0 indicates greater impairment/worse performance for CDR-SB and ADASCog13 scales and improved functioning for ADCS-ADL-MCI. For ADCS-ADL-MCI, z-score were reversed (new reversed value=original value-1) to make interpretation consistent. The GST z-score of 0 indicates population mean and score\>0 indicate greater impairment/worse performance.

Trial Locations

Locations (262)

K2 Medical Research

🇺🇸

Orlando, Florida, United States

Headlands Research LLC

🇺🇸

Orlando, Florida, United States

Conquest Research

🇺🇸

Orlando, Florida, United States

Central States Research, LLC

🇺🇸

Tulsa, Oklahoma, United States

Clinical Trial Network LLC

🇺🇸

Houston, Texas, United States

Central Texas Neurology Consultants

🇺🇸

Round Rock, Texas, United States

University of Texas Health Science Center at San Antonio

🇺🇸

San Antonio, Texas, United States

The Memory Clinic

🇺🇸

Bennington, Vermont, United States

UBC Hospital

🇨🇦

Vancouver, British Columbia, Canada

Centricity Research Halifax

🇨🇦

Halifax, Nova Scotia, Canada

Recherches Neuro-Hippocampe Inc., d/b/a Ottawa Memory Clinic

🇨🇦

Ottawa, Ontario, Canada

Kawartha Centre - Redefining Healthy Aging

🇨🇦

Peterborough, Ontario, Canada

Toronto Memory Program (Neurology Research Inc.)

🇨🇦

Toronto, Ontario, Canada

Centricity Research Toronto LMC

🇨🇦

Toronto, Ontario, Canada

Gilbert Neurology Partners, PLLC

🇺🇸

Gilbert, Arizona, United States

Xenoscience Inc.

🇺🇸

Phoenix, Arizona, United States

Banner Alzheimer's Institute

🇺🇸

Tucson, Arizona, United States

Barrow Neurological Institute

🇺🇸

Phoenix, Arizona, United States

HonorHealth Neurology

🇺🇸

Scottsdale, Arizona, United States

Mayo Clinic Arizona

🇺🇸

Scottsdale, Arizona, United States

Banner Sun Health Research Institute

🇺🇸

Sun City, Arizona, United States

Infinity Clinical Research, LLC

🇺🇸

Hollywood, Florida, United States

Charter Research, LLC

🇺🇸

Lady Lake, Florida, United States

ARS - Lake Oconee

🇺🇸

Lakeland, Florida, United States

Medical Research Center

🇺🇸

Miami, Florida, United States

Renstar Medical Research

🇺🇸

Ocala, Florida, United States

K2 Medical Research, LLC

🇺🇸

Orlando, Florida, United States

Nova Clinical Research, LLC

🇺🇸

Bradenton, Florida, United States

JY Research Institute

🇺🇸

Cutler Bay, Florida, United States

Brain Matters Research

🇺🇸

Stuart, Florida, United States

Neurology Offices of South Florida, PLLC

🇺🇸

Boca Raton, Florida, United States

ECommunity Research, LLC

🇺🇸

Boca Raton, Florida, United States

The Neuron Clinic

🇺🇸

San Marcos, California, United States

Syrentis Clinical Research

🇺🇸

Santa Ana, California, United States

California Neuroscience Research, LLC

🇺🇸

Sherman Oaks, California, United States

Inage Neurology and Memory Clinic

🇯🇵

Chiba-shi, Chiba-Ken, Japan

Viking Clinical Research Center

🇺🇸

Temecula, California, United States

Hakuyokai Kashiwado Hospital

🇯🇵

Chiba-shi, Chiba-Ken, Japan

Health Initiatives Research

🇺🇸

Fayetteville, Arkansas, United States

Sun Valley Behaivoral Med Center

🇺🇸

El Centro, California, United States

Neuropain Medical Center

🇺🇸

Fresno, California, United States

Neurology Center of North Orange County

🇺🇸

Fullerton, California, United States

Irvine Center for Clinical Research, Inc.

🇺🇸

Irvine, California, United States

Mary S. Easton Center for Alzheimer's Disease Research, UCLA

🇺🇸

Los Angeles, California, United States

Hoag Memorial Hospital Presbyterian

🇺🇸

Newport Beach, California, United States

Stanford Hospital and Clinics

🇺🇸

Palo Alto, California, United States

VA Palo Alto Health Care System

🇺🇸

Palo Alto, California, United States

Anderson Clinical Research

🇺🇸

Redlands, California, United States

Sutter Health-San Francisco

🇺🇸

San Francisco, California, United States

University of California San Francisco (PARENT)

🇺🇸

San Francisco, California, United States

University of Colorado Anschutz Medical Campus

🇺🇸

Aurora, Colorado, United States

Mountain Neurological Research Center

🇺🇸

Basalt, Colorado, United States

Yale University

🇺🇸

Fairfield, Connecticut, United States

Institute for Neurodegenerative Disorders (IND)

🇺🇸

New Haven, Connecticut, United States

Yale University School Of Medicine

🇺🇸

New Haven, Connecticut, United States

Research Center for Clinical Studies, Inc.

🇺🇸

Norwalk, Connecticut, United States

Howard University Health Sciences

🇺🇸

Washington, District of Columbia, United States

Neurology of Central Florida Research Center, LLC

🇺🇸

Altamonte Springs, Florida, United States

JEM Research Institute

🇺🇸

Atlantis, Florida, United States

Neuropsychiatric Research Center of Southwest Florida

🇺🇸

Fort Myers, Florida, United States

Quantum Laboratories Inc.

🇺🇸

Pompano Beach, Florida, United States

United Medical Research

🇺🇸

Port Orange, Florida, United States

K2 Medical Research Tampa

🇺🇸

Tampa, Florida, United States

USF Health Byrd Institute

🇺🇸

Tampa, Florida, United States

Hawaii Pacific Neuroscience

🇺🇸

Honolulu, Hawaii, United States

Great Lakes Clinical Trials, LLC Ravenswood dba Flourish Research

🇺🇸

Chicago, Illinois, United States

University of Chicago Medical Center

🇺🇸

Chicago, Illinois, United States

Alexian Brothers Medical Center - Neuroscience Research Institute

🇺🇸

Elk Grove Village, Illinois, United States

Indiana University School of Medicine

🇺🇸

Indianapolis, Indiana, United States

University of Kansas Medical Center Research Institute, Inc.

🇺🇸

Fairway, Kansas, United States

Ascension Via Christi Research, a division of Ascension Via Christi Hospitals Wichita, Inc.

🇺🇸

Wichita, Kansas, United States

University of Kentucky Medical Center

🇺🇸

Lexington, Kentucky, United States

Ochsner Health System PARENT

🇺🇸

New Orleans, Louisiana, United States

LSU Health Sciences Center Shreveport

🇺🇸

Shreveport, Louisiana, United States

University of Maryland Medical Center

🇺🇸

Baltimore, Maryland, United States

McLean Hospital

🇺🇸

Belmont, Massachusetts, United States

Brigham and Women's Hospital Department of Neurology

🇺🇸

Boston, Massachusetts, United States

Beth Israel Deaconess Medical Center

🇺🇸

Boston, Massachusetts, United States

ActivMed Practices and Research

🇺🇸

Methuen, Massachusetts, United States

Boston Center for Memory

🇺🇸

Newton, Massachusetts, United States

Donald S. Marks, M.D., P.C.

🇺🇸

Plymouth, Massachusetts, United States

Wayne State University - Detroit Medical Center

🇺🇸

Detroit, Michigan, United States

Michigan Institute for Neurological Disorders

🇺🇸

Farmington Hills, Michigan, United States

Center for Memory and Aging

🇺🇸

Saint Paul, Minnesota, United States

Hattiesburg Clinic, PA

🇺🇸

Hattiesburg, Mississippi, United States

Sharlin Health and Neurology

🇺🇸

Ozark, Missouri, United States

University of Nebraska Medical Center

🇺🇸

Omaha, Nebraska, United States

Cleveland Clinic Lou Ruvo Center for Brain Health

🇺🇸

Las Vegas, Nevada, United States

Las Vegas Medical Research

🇺🇸

Las Vegas, Nevada, United States

The Cognitive Research Center of New Jersey

🇺🇸

Springfield, New Jersey, United States

CenExel Advanced Memory Research Institute of NJ

🇺🇸

Toms River, New Jersey, United States

Neurological Associates of Albany, PC

🇺🇸

Albany, New York, United States

Dent Neurologic Institute

🇺🇸

Amherst, New York, United States

Social Psychiatry Research Institute (SPRI)

🇺🇸

Brooklyn, New York, United States

New York University Medical Center PRIME

🇺🇸

New York, New York, United States

Mount Sinai

🇺🇸

New York, New York, United States

South Shore Neurologic Associates, P.C.

🇺🇸

Patchogue, New York, United States

Finger Lakes Clinical Research

🇺🇸

Rochester, New York, United States

University of Rochester - PARENT

🇺🇸

Rochester, New York, United States

Richmond Behavioral Associates ERG Clinical Research - New York PLLC

🇺🇸

Staten Island, New York, United States

Stony Brook University Hospital

🇺🇸

Stony Brook, New York, United States

SUNY Upstate Medical University

🇺🇸

Syracuse, New York, United States

IMA Evaluations LLC

🇺🇸

Tarrytown, New York, United States

Duke University

🇺🇸

Durham, North Carolina, United States

AMC Research, LLC

🇺🇸

Matthews, North Carolina, United States

Wake Forest Baptist Health Sciences

🇺🇸

Winston-Salem, North Carolina, United States

Cleveland Clinic Foundation

🇺🇸

Cleveland, Ohio, United States

Ohio State University Medical Center

🇺🇸

Columbus, Ohio, United States

Neuro-Behavioral Clinical Research, Inc.

🇺🇸

North Canton, Ohio, United States

Lynn Health Science Institute

🇺🇸

Oklahoma City, Oklahoma, United States

Oregon Health & Science University (OHSU)

🇺🇸

Portland, Oregon, United States

Abington Neurological Associates, LTD

🇺🇸

Abington, Pennsylvania, United States

The Clinical Trial Center, LLC

🇺🇸

Jenkintown, Pennsylvania, United States

Penn Memory Center

🇺🇸

Philadelphia, Pennsylvania, United States

Rhode Island Hospital

🇺🇸

East Providence, Rhode Island, United States

Rhode Island Mood & Memory Research Institute

🇺🇸

East Providence, Rhode Island, United States

Butler Hospital

🇺🇸

Providence, Rhode Island, United States

Coastal Neurology PA

🇺🇸

Port Royal, South Carolina, United States

Neurology Clinic, PC

🇺🇸

Cordova, Tennessee, United States

Genesis Neuroscience Clinic

🇺🇸

Knoxville, Tennessee, United States

Senior Adult Specialty Research

🇺🇸

Austin, Texas, United States

Headlands Research - Brownsville

🇺🇸

Brownsville, Texas, United States

Kerwin Medical Center

🇺🇸

Dallas, Texas, United States

UT Southwestern Medical Center

🇺🇸

Dallas, Texas, United States

University of North Texas Health Science Center

🇺🇸

Fort Worth, Texas, United States

Baylor College Of Medicine

🇺🇸

Houston, Texas, United States

The Methodist Hospital Research Institute

🇺🇸

Houston, Texas, United States

University of Virginia Health System

🇺🇸

Charlottesville, Virginia, United States

Glennan Center for Geriatrics and Gerontology

🇺🇸

Norfolk, Virginia, United States

National Clinical Research Inc. - Richmond

🇺🇸

Richmond, Virginia, United States

University of Washington Medical Center

🇺🇸

Seattle, Washington, United States

Kingfisher Cooperative, LLC

🇺🇸

Spokane, Washington, United States

University of Wisconsin-Madison

🇺🇸

Madison, Wisconsin, United States

Marshfield Clinic

🇺🇸

Marshfield, Wisconsin, United States

Medical College of Wisconsin, Inc.

🇺🇸

Milwaukee, Wisconsin, United States

St Vincent's Hospital Sydney

🇦🇺

Darlinghurst, New South Wales, Australia

KaRa Institute of Neurological Diseases

🇦🇺

Macquarie Park, New South Wales, Australia

Box Hill Hospital

🇦🇺

Box Hill, Victoria, Australia

Frankston Hospital

🇦🇺

Frankston, Victoria, Australia

Austin Health

🇦🇺

Heidelberg, Victoria, Australia

The Alfred Hospital

🇦🇺

Melbourne, Victoria, Australia

Royal Melbourne Hospital

🇦🇺

Parkville, Victoria, Australia

Australian Alzheimer's Research Foundation

🇦🇺

Nedlands, Western Australia, Australia

UZ Leuven

🇧🇪

Leuven, Flemish Brabant, Belgium

AZ Sint-Jan

🇧🇪

Brugge, Belgium

Universitair Ziekenhuis Brussel

🇧🇪

Brussel, Belgium

AZ Groeninge

🇧🇪

Kortrijk, Belgium

Trial Tech Tecnologia em Pesquisas com Medicamentos Ltda

🇧🇷

Curitiba, Paraná, Brazil

Instituto de Neurologia de Curitiba - Hospital Ecoville

🇧🇷

Curitiba, Paraná, Brazil

IMV Pesquisa Neurologica Sociedade Simples Ltda

🇧🇷

Porto Alegre, Rio Grande Do Sul, Brazil

Instituto do Cerebro do Rio Grande do Sul

🇧🇷

Porto Alegre, Rio Grande Do Sul, Brazil

IPq-HCFMUSP - Instituto de Psiquiatria do Hospital das Clínicas da FMUSP

🇧🇷

São Paulo, Sao Paulo, Brazil

University of Calgary - Heritage Medical Research Clinic

🇨🇦

Calgary, Alberta, Canada

Sunnybrook Health Sciences Centre

🇨🇦

Toronto, Ontario, Canada

Toronto Western Hospital

🇨🇦

Toronto, Ontario, Canada

Baycrest Centre for Geriatric Care

🇨🇦

Toronto, Ontario, Canada

Clinique de la Memoire de l'Outaouais

🇨🇦

Gatineau, Quebec, Canada

MoCA Research and Innovation Inc

🇨🇦

Greenfield-Park, Quebec, Canada

Montreal Neurological Institute Clinical Research Unit

🇨🇦

Montréal, Quebec, Canada

CHU de Quebec- Hopital de l Enfant Jesus

🇨🇦

Quebec, Canada

Terveystalo Ruoholahti

🇫🇮

Helsinki, Finland

CRST, Clinical Research Services Turku

🇫🇮

Turku, Finland

CHU Strasbourg - Hôpital Hautepierre

🇫🇷

Strasbourg Cedex, Bas Rhin, France

Hôpital de la Timone

🇫🇷

Marseille cedex 05, Bouches-du-Rhône, France

Groupe Hospitalier Pellegrin - Hôpital Pellegrin

🇫🇷

Bordeaux Cedex, Gironde, France

Hôpital La Grave

🇫🇷

Toulouse Cedex 9, Haute Garonne, France

Hopital Gui de Chauliac

🇫🇷

Montpellier, Herault, France

CHU Rennes - Pontchaillou

🇫🇷

Rennes cedex 9, Ille Et Vilaine, France

CHU Nantes - Hopital Nord Laënnec

🇫🇷

Saint-Herblain, Loire Atlantique, France

Hopital Roger Salengro - CHU Lille

🇫🇷

Lille Cedex, Nord, France

Hôpital Lariboisière

🇫🇷

Paris cedex 10, Paris, France

Hôpital des Chapennes

🇫🇷

Villeurbanne, Rhone, France

Groupe Hospitalier Pitie-Salpetriere

🇫🇷

Paris, France

Hôpital Broca

🇫🇷

Paris, France

Universitaetsklinikum Freiburg

🇩🇪

Freiburg, Baden Wuerttemberg, Germany

ISPG - Institut fuer Studien zur Psychischen Gesundheit

🇩🇪

Mannheim, Baden Wuerttemberg, Germany

Universitaetsklinikum Tuebingen

🇩🇪

Tuebingen, Baden Wuerttemberg, Germany

Klinikum Bayreuth GmbH- Hohe Warte

🇩🇪

Bayreuth, Bayern, Germany

Institut fuer Schlaganfall- und Demenzforschung (ISD)

🇩🇪

Muenchen, Bayern, Germany

Klinikum rechts der Isar der TU Muenchen

🇩🇪

Muenchen, Bayern, Germany

Zentrum für klinische Forschung Dr.med. Irma Schöll

🇩🇪

Bad Homburg, Hessen, Germany

Universitaetsklinikum Frankfurt Goethe-Universitaet

🇩🇪

Frankfurt, Hessen, Germany

Universitaetsmedizin Greifswald

🇩🇪

Greifswald, Mecklenburg Vorpommern, Germany

Universitaetsmedizin Goettingen

🇩🇪

Goettingen, Niedersachsen, Germany

Katholisches Klinikum Bochum gGmbH

🇩🇪

Bochum, Nordrhein Westfalen, Germany

Deutsches Zentrum fuer Neurodegenerative Erkrankungen (DZNE)

🇩🇪

Bonn, Nordrhein Westfalen, Germany

Universitaetsklinikum Duesseldorf AoeR

🇩🇪

Duesseldorf, Nordrhein Westfalen, Germany

Universitaetsklinikum Koeln

🇩🇪

Koeln, Nordrhein Westfalen, Germany

Universitaetsklinikum Magdeburg

🇩🇪

Magdeburg, Sachsen Anhalt, Germany

Universitaetsklinikum Carl Gustav Carus TU Dresden

🇩🇪

Dresden, Sachsen, Germany

NEUROZENTRUM tempelhof.berlin

🇩🇪

Berlin, Germany

Charité - Universitätsmedizin Berlin

🇩🇪

Berlin, Germany

Azienda Ospedaliera Card. G. Panico

🇮🇹

Tricase, Lecce, Italy

ASST di Monza

🇮🇹

Monza, Milano, Italy

Fondazione Istituto G.Giglio di Cefalù

🇮🇹

Cefalù, Palermo, Italy

Ospedale di Arzignano

🇮🇹

Arzignano VI, Vicenza, Italy

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia (Presidio Spedali Civili)

🇮🇹

Brescia, Italy

IRCCS Ospedale Policlinico San Martino

🇮🇹

Genova, Italy

Ospedale San Raffaele

🇮🇹

Milano, Italy

Azienda Ospedaliera Universitaria- Università degli Studi della Campania "Luigi Vanvitelli"

🇮🇹

Napoli, Italy

Azienda Ospedaliera e Universitaria di Perugia

🇮🇹

Perugia, Italy

Fondazione Santa Lucia IRCCS

🇮🇹

Roma, Italy

Azienda Ospedaliera Universitaria Policlinico Umberto I - Università di Roma La Sapienza

🇮🇹

Roma, Italy

Azienda Ospedaliera Universitaria OO. RR. S. Giovanni di Dio e Ruggi D'Aragona

🇮🇹

Salerno, Italy

National Center For Geriatrics And Gerontology

🇯🇵

Obu-shi, Aichi-Ken, Japan

Southern Tohoku Medical Clinic

🇯🇵

Koriyama-shi, Fukushima-Ken, Japan

NHO Hiroshima-Nishi Medical Center

🇯🇵

Otake-shi, Hiroshima-Ken, Japan

Himeji Central Hospital Clinic

🇯🇵

Himeji-shi, Hyogo-Ken, Japan

Kagawa University Hospital

🇯🇵

Kita-gun, Kagawa-Ken, Japan

Tokushukai Shonan Atsugi Hospital

🇯🇵

Atsugi-shi, Kanagawa-Ken, Japan

Tokushukai Shonan Kamakura General Hospital

🇯🇵

Kamakura-shi, Kanagawa-Ken, Japan

Teikyo University Hospital, Mizonokuchi

🇯🇵

Kawasaki-shi, Kanagawa-Ken, Japan

Rakuwakai Otowa Rehabilitation Hospital

🇯🇵

Kyoto-shi, Kyoto-Fu, Japan

NHO Utano National Hospital

🇯🇵

Kyoto-shi, Kyoto-Fu, Japan

Katayama Medical Clinic

🇯🇵

Kurashiki-shi, Okayama-Ken, Japan

Tokushukai Kishiwada Tokushukai Hospital

🇯🇵

Kishiwada-shi, Osaka-Fu, Japan

Osaka University Hospital

🇯🇵

Suita-shi, Osaka-Fu, Japan

Midorikai Takesato Hospital

🇯🇵

Kasukabe-shi, Saitama-Ken, Japan

Memory Clinic Ochanomizu

🇯🇵

Bunkyo-ku, Tokyo-To, Japan

National Center of Neurology and Psychiatry

🇯🇵

Kodaira-shi, Tokyo-To, Japan

Tokushukai Yamagata Tokushukai Hospital

🇯🇵

Yamagata-shi, Yamagata-Ken, Japan

Seoul National University Bundang Hospital

🇰🇷

Seongnam, Gyeonggi-do, Korea, Republic of

Konkuk University Medical Center

🇰🇷

Seoul, Korea, Republic of

Asan Medical Center

🇰🇷

Seoul, Korea, Republic of

Health Pharma Professional Research S.A. de C.V.

🇲🇽

Ciudad de México, Distrito Federal, Mexico

Hospital Mexico Americano SC

🇲🇽

Guadalara, Jalisco, Mexico

Hospital Universitario Dr. Jose Eleuterio Gonzalez

🇲🇽

Monterrey, Nuevo León, Mexico

Centro de Estudios Clinicos y Especialidades Medicas, S.C.

🇲🇽

Monterrey, Nuevo León, Mexico

AVIX Investigación Clínica S.C

🇲🇽

Monterrey, Nuevo León, Mexico

PROMENTE Sp. z o.o.

🇵🇱

Bydgoszcz, Kujawsko-Pomorskie Województwo, Poland

Centrum Medyczne NeuroProtect

🇵🇱

Warszawa, Mazowieckie Województwo, Poland

Podlaskie Centrum Psychogeriatrii

🇵🇱

Bialystok, Podkarpackie Wojewódctwo, Poland

Centrum Medyczne Senior

🇵🇱

Sopot, Pomorskie Województwo, Poland

Samodzielny Publiczny Szpital Kliniczny Nr 4 w Lublinie Kliniczny Oddział Neurologii Oddział Udarowy

🇵🇱

Lublin, Poland

NZOZ Wroclawskie Centrum Alzheimerowskie

🇵🇱

Wroclaw, Poland

Nzoz Novo-Med

🇵🇱

Katowice, Śląskie Województwo, Poland

Neuro-Care Gabriela Klodowska

🇵🇱

Siemianowice Slaskie, Śląskie Województwo, Poland

Hospital Universitario Reina Sofia

🇪🇸

Cordoba, Córdoba, Spain

Policlinica Gipuzkoa

🇪🇸

San Sebastian, Guipuzcoa, Spain

Clinica Universidad de Navarra

🇪🇸

Pamplona, Navarra, Spain

Fundacio ACE

🇪🇸

Barcelona, Spain

Hospital Clinic de Barcelona

🇪🇸

Barcelona, Spain

Hospital de la Santa Creu i Sant Pau

🇪🇸

Barcelona, Spain

Hospital Universitari de Santa Maria

🇪🇸

Lleida, Spain

Clinica Universidad de Navarra (MAD)

🇪🇸

Madrid, Spain

Hospital Victoria Eugenia

🇪🇸

Sevilla, Spain

Hospital Universitario Dr. Peset

🇪🇸

Valencia, Spain

Hospital Universitari i Politecnic La Fe

🇪🇸

Valencia, Spain

Skane University Hospital

🇸🇪

Malmö, Scania, Sweden

Sahlgrenska Universitetssjukhuset, Mölndal Sjukhus

🇸🇪

Mölndal, Västra Götaland, Sweden

Karolinska Universitetssjukhuset

🇸🇪

Stockholm, Sweden

The University of Edinburgh

🇬🇧

Edinburgh, East Lothian, United Kingdom

Institute of Psychiatry, Psychology and Neuroscience

🇬🇧

London, Greater London, United Kingdom

Re:Cognition Health Ltd (London)

🇬🇧

London, Greater London, United Kingdom

Charing Cross Hospital

🇬🇧

London, Greater London, United Kingdom

Park House

🇬🇧

Manchester, Greater Manchester, United Kingdom

Southampton General Hospital

🇬🇧

Southampton, Hampshire, United Kingdom

Moorgreen Hospital

🇬🇧

Southampton, Hampshire, United Kingdom

Brain Health Scotland Life Sciences

🇬🇧

Edinburgh, Lothian Region, United Kingdom

The RICE Centre

🇬🇧

Bath, Somerset, United Kingdom

Glasgow Memory Clinic Ltd

🇬🇧

Motherwell, Strathclyde, United Kingdom

Re Cognition Health Bristol

🇬🇧

Bristol, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath